uniQure Announces First Quarter 2018 Financial Results and Highlights Company Progress

Apr 30, 2018 11:05 am UTC| Business

~ Patient enrollment expected to begin ahead of schedule in dose-confirmation study for AMT-061 and pivotal study on track to commence in third quarter of 2018 ~ IND filing for AMT-130 in Huntington’s Disease expected in...

K. Hovnanian Enterprises, Inc. Announces Amendments to Exchange Offer and Consent Solicitation

Apr 30, 2018 11:01 am UTC| Business

MATAWAN, N.J., April 30, 2018 -- Hovnanian Enterprises, Inc. (NYSE:HOV) (the “Company”) announced today that its wholly-owned subsidiary, K. Hovnanian Enterprises, Inc. (the “Issuer”), has amended certain terms of its...

U.S. FDA Clears Pluristem’s IND to Treat Victims Exposed to Acute Radiation

Apr 30, 2018 11:01 am UTC| Business

HAIFA, Israel, April 30, 2018 -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that the U.S. Food and Drug Administration (FDA) has...

DSP Group, Inc. Reports First Quarter 2018 Results

Apr 30, 2018 11:01 am UTC| Business

Growth Initiatives Account for 50% of Total Revenues for the First Time  DSP...

Lucky Minerals Executes Definitive Agreement for Acquisition of Goldmindex and Its 54,985 Hectares of Contiguous Mineral Concessions in the Heart of Ecuadors Main Mining Province

Apr 30, 2018 11:01 am UTC| Business

VANCOUVER, B.C., April 30, 2018 -- Lucky Minerals Inc. (TSX.V: LJ) (OTCQB: LKMNF) (FRA:8LM) (“Lucky” or the “Company”) is pleased to announce that, further to the Company’s news release of April 11, 2018, it...

Gopher Protocol Inc. Appoints Independent Director

Apr 30, 2018 11:01 am UTC| Business

New Member Will Head Audit Committee to be Formed SANTA MONICA, CA, April 30, 2018 -- Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher"), a technology company which specializes in the creation of Internet of Things...

Elto PharmaAppoints Paula Trzepacz, MD asChief Medical Advisor

Apr 30, 2018 11:01 am UTC| Business

Ex-Lilly Sr. Medical Fellow in Neurosciences to lead Parkinson's Phase 2b redesign NEW YORK, April 30, 2018 --  via OTC PR WIRE -- Elto Pharma, Inc., a specialty pharmaceutical, clinical-stage wholly-owned subsidiary...